Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery

Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery, A Randomized Control Trial

This study has two main goals: 1) to refine and enhance the R2R-TBI intervention; and 2) to examine the efficacy of the R2R-TBI intervention in a randomized control trial. To achieve the second goal, we will employ a between-groups randomized treatment design with repeated measures at baseline, one-month post-randomization, and at a six-month follow-up. The two conditions will be: a) usual medical care plus access to internet resources regarding pediatric brain injury (Internet Resources Comparison group, IRC), and b) usual medical care plus the R2R-TBI intervention (Road-to-Recovery group, R2R-TBI).

Study Overview

Detailed Description

The early recovery period constitutes a critical window to set families on a positive road-to-recovery by supporting parental self-care, positive parent-child interactions, and awareness of potential longer-term concerns. The latter would facilitate parental recognition of behavioral and psychosocial needs that might otherwise go unmet.

Recognizing that (1) caregivers of children who have sustained TBI are at risk of worsening psychological health and that (2) caregiver functioning and parenting behaviors have a direct impact on child recovery and outcomes; intervening and supporting caregivers in the acute phase following injury may set children and families on a positive path to recovery. Intervening at the acute phase may reduce the cascading effects of parental burden/distress and concomitant negative parent-child interactions on child recovery and functioning over time.

Because families of children with TBI and other chronic health conditions may have difficulty accessing services due to transportation and cost issues, particularly lower income families, the R2R-TBI program is designed to be accessed via any web-enabled device (e.g., smartphone, computer, tablet) with any form of internet connection. We will also offer the intervention (via tablet) to parents while they wait for their child to complete outpatient therapies (e.g., speech, physical, and occupational therapy). Delivery of web-based behavioral health interventions may reduce barriers to help-seeking and promote evidence-based interventions that are both accessible and efficient.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Caregivers will be eligible if they are over 18 years of age, and if their child meets all of the following criteria:

  • Ages 3 months to 18 years at time of discharge from hospital
  • Sustained a complicated mild to severe TBI as defined by a Glasgow Coma Scale (GCS) of 13-15 with imagining abnormalities or GCS 3-12 with or without imaging abnormalities
  • Admitted overnight to the hospital
  • 0-3 months post-discharge

Exclusion Criteria:

The caregiver will be excluded from participation if any of the following occur:

  • Child did not survive the injury
  • Child sustained a non-blunt head trauma (e.g. gunshot wound)
  • Child does not reside with parent/caregiver for study duration
  • English is not primary language spoken in the home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Road-to-recovery group (R2R)
Usual medical care plus the R2R-TBI intervention (self-guided web-program)
R2R-TBI is a self-guided web-based intervention that targets caregiver psychological functioning, parenting behaviors, and family functioning in the first three months following pediatric traumatic brain injury.
Active Comparator: Internet resources comparison group (IRC)
Usual medical care plus internet resources
R2R-TBI is a self-guided web-based intervention that targets caregiver psychological functioning, parenting behaviors, and family functioning in the first three months following pediatric traumatic brain injury.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parent anxiety
Time Frame: Change from baseline at 4-6 weeks post-intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Measure 4a; scores range from 4-20 with higher score indicating greater symptoms of anxiety
Change from baseline at 4-6 weeks post-intervention
Parent anxiety
Time Frame: Change from baseline at 6 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Measure 4a; scores range from 4-20 with higher score indicating greater symptoms of anxiety
Change from baseline at 6 months
Parent depression
Time Frame: Change from baseline at 4-6 weeks post-intervention
Center for Epidemiological Studies Depression Scale (CES-D; 10-items); scores range from 0 -30 with higher scores indicating of higher levels of depressive symptomatology
Change from baseline at 4-6 weeks post-intervention
Parent depression
Time Frame: Change from baseline at 6 months
Center for Epidemiological Studies Depression Scale (CES-D; 10-items); scores range from 0 -30 with higher scores indicating of higher levels of depressive symptomatology
Change from baseline at 6 months
Parenting self-efficacy
Time Frame: Change from baseline at 4-6 weeks post-intervention
Caregiver self-efficacy scale (CSES); scores range from 25-100, higher scores indicate greater parenting self efficacy
Change from baseline at 4-6 weeks post-intervention
Parenting self-efficacy
Time Frame: Change from baseline at 6 months
Caregiver self-efficacy scale (CSES); scores range from 25-100, higher scores indicate greater parenting self efficacy
Change from baseline at 6 months
Parent post-traumatic symptoms
Time Frame: Change from baseline at 4-6 weeks post-intervention
Primary Care PTSD Screen for DSM-5 (PC-PTSD-5); scores rage from 0-5 with higher scores indicating greater experience of post-traumatic stress symptoms
Change from baseline at 4-6 weeks post-intervention
Parent post-traumatic symptoms
Time Frame: Change from baseline at 6 months
Primary Care PTSD Screen for DSM-5 (PC-PTSD-5); scores rage from 0-5 with higher scores indicating greater experience of post-traumatic stress symptoms
Change from baseline at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family Functioning
Time Frame: Change from baseline at 4-6 weeks post-intervention
Family Assessment Device - Global Functioning Scale. Scores range from 1 to 4 with higher scores indicating poorer family functioning
Change from baseline at 4-6 weeks post-intervention
Family Functioning
Time Frame: Change from baseline at 6 months
Family Assessment Device - Global Functioning Scale. Scores range from 1 to 4 with higher scores indicating poorer family functioning
Change from baseline at 6 months
Family Burden of Injury
Time Frame: Change from baseline at 4-6 weeks post-intervention
Family Burden of Injury Interview (FBII). Average scores range from 0-4; higher scores indicate greater injury-related burden
Change from baseline at 4-6 weeks post-intervention
Family Burden of Injury
Time Frame: Change from baseline at 6 months
Family Burden of Injury Interview (FBII). Average scores range from 0-4; higher scores indicate greater injury-related burden
Change from baseline at 6 months
Child Socioemotional Functioning
Time Frame: Change from baseline at 4-6 weeks post-intervention
Pediatric Quality of Life Scale (PEDS-QL) - Psychosocial Health Summary Score (score range varies based on child age; higher scores indicate greater health related quality of life)
Change from baseline at 4-6 weeks post-intervention
Child Socioemotional Functioning
Time Frame: Change from baseline at 6 months
Pediatric Quality of Life Scale (PEDS-QL) - Psychosocial Health Summary Score (score range varies based on child age; higher scores indicate greater health related quality of life)
Change from baseline at 6 months
Parent mindful self-care
Time Frame: Change from baseline at 4-6 weeks post-intervention
Mindful self-care scale (MSCS); scores range from 6 - 30, higher scores denote greater frequency in engaging in self-care behaviors
Change from baseline at 4-6 weeks post-intervention
Parent mindful self-care
Time Frame: Change from baseline at 6 months
Mindful self-care scale (MSCS); scores range from 6 - 30, higher scores denote greater frequency in engaging in self-care behaviors
Change from baseline at 6 months
Parent resilience
Time Frame: Change from baseline at 4-6 weeks post-intervention
Connor-Davidson Resilience Scale (CDRI); scores range from 0-40 with higher scored indicating greater resilience
Change from baseline at 4-6 weeks post-intervention
Parent resilience
Time Frame: Change from baseline at 6 months
Connor-Davidson Resilience Scale (CDRI); scores range from 0-40 with higher scored indicating greater resilience
Change from baseline at 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moderators of treatment effects
Time Frame: 4-6 weeks
Examining household income and baseline caregiver distress as moderator of treatment effects
4-6 weeks
Moderators of treatment effects
Time Frame: 6 months
Examining household income and baseline caregiver distress as moderator of treatment effects
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shari Wade, PhD, CCHMC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2023

Primary Completion (Estimated)

July 30, 2024

Study Completion (Estimated)

October 30, 2024

Study Registration Dates

First Submitted

October 24, 2022

First Submitted That Met QC Criteria

November 14, 2022

First Posted (Actual)

November 18, 2022

Study Record Updates

Last Update Posted (Estimated)

June 2, 2023

Last Update Submitted That Met QC Criteria

May 31, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Plan is to share deidentified data as consistent with requirement of funding source (i.e., The National Institute on Disability and Rehabilitation Research).

IPD Sharing Time Frame

Starting 6 months after publication

IPD Sharing Access Criteria

Plan is to share deidentified data as consistent with protocols of funding source (i.e., The National Institute on Disability and Rehabilitation Research).

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Clinical Trials on Road-to-recovery

3
Subscribe